Preclinical News and Research

RSS
Investigational drug shows promising results for treating HNSCC tumors

Investigational drug shows promising results for treating HNSCC tumors

Study reports highly potent anti-SARS-CoV-2 compounds

Study reports highly potent anti-SARS-CoV-2 compounds

Researchers launch randomized, placebo-controlled clinical trial of pulmozyme in COVID-19 patients

Researchers launch randomized, placebo-controlled clinical trial of pulmozyme in COVID-19 patients

Simple blood test may be a great advance for people with and at risk for Alzheimer's

Simple blood test may be a great advance for people with and at risk for Alzheimer's

A new cell-based gene therapy approach to better treat patients with hemophilia A

A new cell-based gene therapy approach to better treat patients with hemophilia A

Discovery could pave way for a blood test to diagnose Alzheimer's before symptoms appear

Discovery could pave way for a blood test to diagnose Alzheimer's before symptoms appear

Novel drug candidate offers a major advance in the treatment for diabetes

Novel drug candidate offers a major advance in the treatment for diabetes

Two-step targeting strategy can increase clinical translation of nanoparticle-based therapies

Two-step targeting strategy can increase clinical translation of nanoparticle-based therapies

Curi Bio Acquires Dana Solutions

Curi Bio Acquires Dana Solutions

Study finds a sharp decline in heart transplants during the pandemic

Study finds a sharp decline in heart transplants during the pandemic

Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals

Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals

Researchers discover new method to treat herpes viruses

Researchers discover new method to treat herpes viruses

Boehringer Ingelheim and Biognosys join forces on applying quantitative proteomics tools in drug discovery

Boehringer Ingelheim and Biognosys join forces on applying quantitative proteomics tools in drug discovery

Study shows inert drug ingredients could lead to unanticipated side effects

Study shows inert drug ingredients could lead to unanticipated side effects

Hollings Cancer Center researcher receives NCI grants for cancer immunotherapy studies

Hollings Cancer Center researcher receives NCI grants for cancer immunotherapy studies

Gene signature explains why 18F-FDG imaging performs better for PSMA-suppressed prostate cancer patients

Gene signature explains why 18F-FDG imaging performs better for PSMA-suppressed prostate cancer patients

New strategy allows long-term, non-invasive tracking of cardiomyocytes

New strategy allows long-term, non-invasive tracking of cardiomyocytes

Eikonoklastes Therapeutics announces closing of oversubscribed seed financing

Eikonoklastes Therapeutics announces closing of oversubscribed seed financing

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.